Transforming growth factor (TGF)-β mediates epithelial mesenchymal transition (EMT) in ovarian cancer by regulating tissue transglutaminase (TG2) involved in cell proliferation, differentiation and apoptosis, and is associated with the development of CSCs. Here, TGM2 is linked to ovarian cancer.